Global InformationGeorge Scangos information
George A. Scangos | |
|---|---|
| Nationality | American |
| Alma mater | Cornell University, University of Massachusetts |
| Scientific career | |
| Fields | Biotechnology |
| Institutions | Johns Hopkins University, Biogen |
| Doctoral advisor | Albey Reiner |
| Other academic advisors | Frank Ruddle |
George A. Scangos was a pharmaceutical executive and former chief executive officer of Vir Biotechnology from 2017 to 2023. Scangos was previously the chief executive officer of Biogen from 2010 to 2016 and of Exelixis from 1996 to 2010.[1][2] Prior to joining industry, Scangos was a professor of biology at Johns Hopkins University.[3][4]
- ^ Fidler, Ben (January 25, 2023). "Veteran biotech leader George Scangos to step down as Vir CEO". BioPharma Dive. Retrieved April 5, 2023.
- ^ "George Scangos". www.bizjournals.com.
- ^ "Biogen Idec Names George Scangos Chief Executive Officer". Retrieved April 5, 2023.
- ^ Ribbink, Kim (March 25, 2009). "Dr. George Scangos: Gene Excellence". PharmaVoice. Retrieved April 6, 2023.